Compounds > phorbol 12,13-dibutyrate
Page last updated: 2024-08-23

phorbol 12,13-dibutyrate and Hyperplasia

phorbol 12,13-dibutyrate has been researched along with Hyperplasia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elias, PM; Galardy, RE; Gao, WN; Holleran, WM; Levy, D; Tang, PC1
Angelini, GD; Jeremy, JY; Khan, MA; Mikhailidis, DP; Morgan, RJ; Thompson, CS1

Other Studies

2 other study(ies) available for phorbol 12,13-dibutyrate and Hyperplasia

ArticleYear
Matrix metalloproteinase inhibitors reduce phorbol ester-induced cutaneous inflammation and hyperplasia.
    Archives of dermatological research, 1997, Volume: 289, Issue:3

    Topics: Animals; Dermatitis, Contact; Dipeptides; Extracellular Matrix; Hyperplasia; Metalloendopeptidases; Mice; Mice, Hairless; Phorbol 12,13-Dibutyrate; Protease Inhibitors; Skin; Tryptophan

1997
Prostaglandins and cyclic nucleotides in the urinary bladder of a rabbit model of partial bladder outlet obstruction.
    Prostaglandins, leukotrienes, and essential fatty acids, 1999, Volume: 61, Issue:5

    Topics: Acetylcholine; Animals; Calcimycin; Cyclic AMP; Cyclic GMP; Dinoprostone; Disease Models, Animal; Epoprostenol; Hyperplasia; Hypertrophy; In Vitro Techniques; Male; Muscle, Smooth; Organ Size; Phorbol 12,13-Dibutyrate; Prostaglandins; Rabbits; Urinary Bladder; Urinary Bladder Neck Obstruction

1999